Expression and clinical significance of serum IGF-I and TSGF in human glioma

Zhou Xu,YUAN Xian-hou,JIANG Pu-cha,Feng Chen,LIU Xi-guo

2009-01-01

Abstract:OBJECTIVE: To investigate the clinical significance of serum IGF-I and TSGF to gliomas. METHODS: Immune radiation measure analysis and spectro photometric method were used to detect the serum level of IGF-I and TSGF in 58 patients with gliomas, 22 patients with intracranial benign tumor and 20 healthy people. RESULTS: The serum level of IGF-I and TSGF in the gliomas group was significant higher than that in the the benign tumor group and healthy group, P < 0.01. The expression between grade I and II of the gliomas have a significant difference (P < 0.05), the difference between grade II, III and IV were extremely significant (P < 0.01), and there was a positive correlation between expression level and the grade of gliomas. The level of expression was also of positive correlation between IGF-I and TSGF. In gliomas, positive rates of IGF-I and TSGF were 78% (45/58) and 74% (43/58), and the positive rate of combined detection was 84% (49/58). CONCLUSION: The serum IGF-I and TSGF of glioma are significant in the early diagnosis and judge the degree of malignancy, screening high-risk groups and prognosis of a certain significance.